Company patents
Pulmonx Corporation
Pulmonx Corporation's patent strategy is heavily concentrated in Medical Diagnostics & Surgery, accounting for 90.9% of its portfolio, yet this category has seen a significant decline in patenting activity, with a 60.0% YoY drop in 2025 and a further 33.3% decline so far in 2026. Surprisingly, despite its medical device focus, the company also shows a minor, yet persistent, interest in Image Processing, with 15.2% of its portfolio, including one patent so far in 2026, suggesting a potential, albeit small, diversification into computing-related medical technologies.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
33 US filings (since 2023) · 6 categories · 5 themes
Systems and devices for delivering gases, aerosols, or pressure support to the respiratory system, often including interfaces like masks and sophisticated control mechanisms for therapeutic effect or airway management.
Systems and methods for non-invasive or minimally invasive collection and analysis of physiological data (e.g., blood pressure, electrolytes, genetic markers, B cell repertoire) to assess patient health status, screen for conditions, or aid in diagnosis.
Design and application of devices that are inserted into the body or implanted to treat diseases, modulate physiological functions, or repair anatomical structures.
Minimally invasive medical devices, typically flexible tubes, inserted into body lumens to deliver substances, remove obstructions, or perform localized treatments like ablation, dialysis, or drainage.
Methods and apparatuses for creating unique package structures, such as recesses in specific materials, blister packages, or single-dose units, and for controlled dispensing of products from storage into these containers.
Patents
Showing 1-10 of 50